Triple

T16185296
Position Surface form Disambiguated ID Type / Status
Subject White Oak Federal Research Center E392784 entity
Predicate tenant P75 FINISHED
Object Office of the Commissioner of Food and Drugs E886012 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Office of the Commissioner of Food and Drugs | Statement: [White Oak Federal Research Center, tenant, Office of the Commissioner of Food and Drugs]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Office of the Commissioner of Food and Drugs
Context triple: [White Oak Federal Research Center, tenant, Office of the Commissioner of Food and Drugs]
  • A. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • B. U.S. Food and Drug Administration Office of the Commissioner chosen
    The U.S. Food and Drug Administration Office of the Commissioner is the central executive office that provides overall leadership, policy direction, and oversight for all FDA regulatory and public health activities.
  • C. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • D. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • E. U.S. Food and Drug Administration Office of Operations
    The U.S. Food and Drug Administration Office of Operations is the FDA component responsible for overseeing the agency’s administrative, financial, and operational support functions across its programs and facilities.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d87f1e49ac8190a311b54d32990576 completed April 10, 2026, 4:39 a.m.
NER Named-entity recognition batch_69e22060dcf88190b7c662946a5f0191 completed April 17, 2026, 11:58 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0017a7223c81909f04144bdffb22ff completed May 10, 2026, 5:29 a.m.
Created at: April 10, 2026, 5:02 a.m.